Rezultaty - Arja Kaipainen
- Rezultaty 1 - 20 Rezultaty od 26
- Idź do następnej strony
-
1
-
2
-
3
-
4
-
5
-
6
Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype od Diane R. Bielenberg, Yasuhiro Hida, Akio Shimizu, Arja Kaipainen, Michael Kreuter, Caroline Choi Kim, Michael Klagsbrun
Wydane 2004Artigo -
7
-
8
-
9
-
10
-
11
-
12
PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition od Dipak Panigrahy, Arja Kaipainen, Sui Huang, Catherine Butterfield, Carmen M. Barnés, Michael Fannon, Andrea Laforme, Deviney M. Chaponis, Judah Folkman, Mark W. Kieran
Wydane 2008Artigo -
13
Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular Tumors od Athina Lymboussaki, Taina A. Partanen, Birgitta Olofsson, Judith Thomas-Crusells, Christopher D.�M. Fletcher, Robert M.W. de Waal, Arja Kaipainen, Kari Alitalo
Wydane 1998Artigo -
14
-
15
Evidence by molecular profiling for a placental origin of infantile hemangioma od Carmen M. Barnés, Sui Huang, Arja Kaipainen, Despina Sanoudou, Emy J. Chen, Gabriel S. Eichler, Yuchun Guo, Ying Yu, Donald E. Ingber, John B. Mulliken, Alan H. Beggs, Judah Folkman, Steven J. Fishman
Wydane 2005Artigo -
16
PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis od Dipak Panigrahy, Samuel Singer, Lucy Q. Shen, Catherine Butterfield, Deborah A. Freedman, Emy J. Chen, Marsha A. Moses, Susan Kilroy, Stefan Duensing, Christopher D.�M. Fletcher, Jonathan A. Fletcher, Lynn Hlatky, Philip Hahnfeldt, Judah Folkman, Arja Kaipainen
Wydane 2002Artigo -
17
PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis od Dipak Panigrahy, Samuel Singer, Lucy Q. Shen, Catherine Butterfield, Deborah A. Freedman, Emy J. Chen, Marsha A. Moses, Susan Kilroy, Stefan Duensing, Christopher D.�M. Fletcher, Jonathan A. Fletcher, Lynn Hlatky, Philip Hahnfeldt, Judah Folkman, Arja Kaipainen
Wydane 2002Artigo -
18
ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumo... od Jeremy N. Rich, Sith Sathornsumetee, Stephen T. Keir, Mark W. Kieran, Andrea Laforme, Arja Kaipainen, Roger E. McLendon, Michael W. Graner, Binish Rasheed, Xuan Wang, David A. Reardon, Anderson J. Ryan, Catherine Wheeler, Isaiah W. Dimery, Darell D. Bigner, Henry S. Friedman
Wydane 2005Artigo -
19
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress od Michael D. Nyquist, Alexandra Corella, Ilsa M. Coleman, Navonil De Sarkar, Arja Kaipainen, Gavin Ha, Roman Gulati, Lisa S. Ang, Payel Chatterjee, Jared M. Lucas, Colin C. Pritchard, Gail P. Risbridger, John T. Isaacs, Bruce Montgomery, Colm Morrissey, Eva Corey, Peter S. Nelson
Wydane 2020Artigo -
20
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer od Alexandra Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa M. Coleman, Jared M. Lucas, Arja Kaipainen, Holly M. Nguyen, Daniel Sondheim, Lisha G. Brown, Lawrence D. True, John K. Lee, David MacPherson, Paul Nghiem, Roman Gulati, Colm Morrissey, Eva Corey, Peter S. Nelson
Wydane 2019Artigo
Narzędzie wyszukiwania:
Podobne hasła
Biology
Cancer research
Cancer
Medicine
Receptor
Endocrinology
Angiogenesis
Biochemistry
Cell biology
Internal medicine
Genetics
Gene
Metastasis
Immunology
Neovascularization
VEGF receptors
Vascular endothelial growth factor
Gene expression
Pathology
In vitro
Inflammation
Prostate cancer
Vascular endothelial growth factor A
Vascular endothelial growth factor C
Endothelial stem cell
Growth factor
Signal transduction
Androgen receptor
Carcinogenesis
Cell growth